Private Equity Firms in India Drive Growth in Healthcare & MedTech

Image
  India’s healthcare sector is witnessing a major transformation, fueled by increasing investments from private equity firms in India . The country, one of the fastest-growing healthcare markets in the world, is attracting substantial capital, particularly in medical technology (MedTech). In 2024, private equity investment in India saw a shift, with funding in MedTech jumping nearly fivefold to $1.2 billion, while investments in hospitals and clinics declined significantly. This shift highlights a growing emphasis on technology, innovation, and improved healthcare infrastructure. The Rise of Private Equity in Indian Healthcare Private equity (PE) and venture capital (VC) firms are showing strong confidence in private equity India , with healthcare emerging as a key sector for investment. The number of PE/VC deals in healthcare surged from 62 in 2023 to 84 in 2024, indicating rising investor interest. However, there is a noticeable change in where the money is going. While hospi...

Role of Technological Advancement in Private Equity Investment

The COVID-19 pandemic has put health care funding back in the limelight. Though much of the current consideration on the sector has centered on the race to develop and deploy a Covid-19 vaccine, the reality is private equity investment into the health care industry has steadily increased over the years. 

Private Equity Investment


With intensified competition, dealmakers will have to take advantage of every means available, and technology has become a critical component of that effort. In today’s remote environment, sharing business intelligence, building relationships, and sourcing new business opportunities all need digital technologies.

To be the best at using technology, dealmakers need a platform that is built to manage the complexities of deal-making in health care. Regardless of the investment plan, health care deals involve a complicated web of partners, sponsors, lawyers, lenders, and advisors. However, once firms adopt a technology platform created to handle deals, relationships, and pipelines, dealmakers can start to build a single source of truth that enables them to share institutional knowledge across the firm. In the end, the quality and convenience of that single source of authenticity are what differentiates the best firms from the rest when it comes to leveraging technology. Dealmakers who can easily obtain exclusive data across critical functions, including business development, fundraising and investor relations, portfolio monitoring, risk management, compliance, and due diligence, can work more efficiently, make better decisions and reduce reliance on colleagues for routine data requests.

Some platforms even take it one step further and integrate with third-party data providers, allowing dealmakers to view the latest market intelligence side-by-side with proprietary data. Much like the global pandemic has shifted the conversation in health care investment; it has also shifted the conversation when it comes to leveraging firm-wide technology. Ultimately, technology provides a 360-degree picture of the business, the factors affecting the industries in which they operate, a historical view of transactions in that market, and so much more.

Comments

Popular posts from this blog

Private Equity’s Role in Tackling Global Healthcare Inequalities

Quadria Capital: Powering Better Healthcare through Private Equity Investment

How Private Equity is Transforming the Healthcare Landscape in Malaysia